1-6 of 6
computed tomography/positron emission tomography imaging
Close
Sort by
Journal Articles

Evidence-Based Minireview: Does achieving MRD negativity after initial therapy improve prognosis for high-risk myeloma patients?

Surbhi Sidana, Elisabet Manasanch
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 142–147.
https://doi.org/10.1182/hematology.2019000075
Published: 2019
Journal Articles

Management of primary central nervous system lymphoma in children

Lisa Giulino-Roth, Oussama Abla, Tracy T. Batchelor
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 386–389.
https://doi.org/10.1182/asheducation-2016.1.386
Published: 2016
Journal Articles

How does PET/CT help in selecting therapy for patients with Hodgkin lymphoma?

Martin Hutchings
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 322–327.
https://doi.org/10.1182/asheducation.V2012.1.322.3800161
Published: 2012
Journal Articles

Interim PET-CT in the management of diffuse large B-cell lymphoma

Craig H. Moskowitz
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 397–401.
https://doi.org/10.1182/asheducation.V2012.1.397.3798512
Published: 2012
Journal Articles

Positron Emission Tomography in the Management of Hodgkin Lymphoma

Joseph M. Connors
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 317–322.
https://doi.org/10.1182/asheducation-2011.1.317
Published: 2011
Journal Articles

The Present: Optimizing Therapy—Too Much or Too Little?

Nancy L. Bartlett
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 108–114.
https://doi.org/10.1182/asheducation-2010.1.108
Published: 2010